腹膜透析市場規模、佔有率和成長分析（按產品、方式、適用疾病、最終用戶、地區）：產業預測（2024-2031）

2022年全球腹膜透析市場規模為84.7億美元，從2023年的89.4億美元成長到2031年的138.3億美元，在預測期內（2024-2031年）預計複合年成長率為5.6%。

腹膜透析（PD）市場由於其相對於傳統血液透析機的優勢而正在經歷顯著成長，特別是對於殘餘腎功能的患者。 PD 對患者來說是一種有吸引力的治療方法，因為它允許靈活的家庭治療、最大限度地減少醫院就診和嚴格的飲食限制。目前家庭透析治療尤其是PD使用的增加體現在2023年至2019年，2年以內的末期腎臟病（ESKD）患者的使用率將從14.8%增加到20%。然而，由於對週期計儀設備的恐懼症，尤其是老年患者，商業性挑戰仍然存在。 COVID-19 後，不斷成長的醫療需求、對創新解決方案的需求以及政府的支持措施預計將推動全球腹膜透析市場的發展，進一步凸顯其在腎臟護理中日益成長的相關性。

目錄

介紹

• 分析目的
• 市場範圍
• 定義

分析方法

• 資訊採購
• 次要/主要資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及前景

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析

主要市場考慮因素

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術分析
• 貿易分析
• 監管分析
• 專利分析
• 案例研究分析

全球腹膜透析市場規模及複合年成長率：按產品分類（2024-2031）

• 市場概況
• 腹膜透析產品
  • 腹膜透析液袋
  • 腹膜透析機
  • 腹膜透析導管
  • 腹膜透析轉運裝置
  • 其他腹膜透析產品
• 腹膜透析服務

全球腹膜透析市場規模及複合年成長率：依方式分類（2024-2031）

• 市場概況
• 連續性移動式腹膜透析（CAPD）
• 自動腹膜透析（APD）

全球腹膜透析市場規模及複合年成長率：依適用疾病分類（2024-2031）

• 市場概況
• 末期腎病
• 急性腎損傷
• 其他疾病

全球腹膜透析市場規模及複合年成長率：按最終用戶分類（2024-2031）

• 市場概況
• 居家醫療
• 醫院/獨立透析中心
• 其他最終用戶

全球腹膜透析市場規模/複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2023年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• 費森尤斯醫療保健股份公司（德國）
• 百特國際公司（美國）
• 美敦力公司（愛爾蘭）
• 達維塔公司（美國）
• 貝克頓迪金森公司（美國）
• 泰爾茂株式會社（日本）
• 猶他醫療產品公司（美國）
• Diaverum AB（瑞典）
• 醫學（美國）
• 紐索爾科技公司（美國）
• 阿波羅透析私人有限公司（印度）
• 美國腎臟護理公司（美國）
• 西北腎臟中心（美國）
• 雷拉沃（美國）
• 米特拉工業私人有限公司（印度）
• JMS有限公司（日本）
• 阿美卡特（中國）
• 綜合醫學（印度）
• 華仁藥業（中國）
• 阿瓦克科技（新加坡）

結論和建議

Global Peritoneal Dialysis Market size was valued at USD 8.47 billion in 2022 and is poised to grow from USD 8.94 billion in 2023 to USD 13.83 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2024-2031).

The peritoneal dialysis (PD) market is experiencing significant growth, driven by its advantages over traditional hemodialysis, particularly for patients with remaining renal function. PD allows for flexible, home-based treatment, minimizing hospital visits and tough dietary restrictions, making it appealing to patients. Today's increasing use of home dialysis, particularly PD, is evident as its utilization rose from 14.8% to 20% among patients with less than two years of end-stage kidney disease (ESKD) between 2023 and 2019. However, commercial challenges persist, especially among older patients, due to technophobia regarding cycler equipment. Post-COVID-19, rising healthcare demands, demand for innovative solutions, and supportive government initiatives are expected to propel the global PD market, further highlighting its growing relevance in renal care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peritoneal Dialysis Market Segmental Analysis

Global Peritoneal Dialysis Market is segmented by offering, modality, disease indication, end user and region. Based on offering, the market is segmented into peritoneal dialysis products and peritoneal dialysis services. Based on modality, the market is segmented into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on disease indication, the market is segmented into end-stage renal disease, acute kidney injury and other diseases. Based on end user, the market is segmented into home care settings, hospitals & independent dialysis centers and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is driven by several key factors, including the rising prevalence of end-stage renal disease (ESRD), advancements in the technology of peritoneal dialysis cyclers, and an increasing demand for home dialysis treatment options. Peritoneal dialysis offers numerous advantages such as lower costs compared to hemodialysis, a needle-free approach, enhanced mobility, ease of use, and fewer dietary restrictions, all of which contribute to its global market growth. Furthermore, the escalating need for home care dialysis services reflects the growing trend of treating both acute and chronic kidney disease patients in outpatient or home settings. With over 800 million individuals affected by chronic kidney disease worldwide, the demand for effective renal home treatments continues to rise, particularly in low- and middle-income countries where the burden is disproportionately significant.

Restraints in the Global Peritoneal Dialysis Market

The global peritoneal dialysis market faces several significant restraints that hinder its growth potential. Key challenges include a heightened risk of infections and complications associated with treatment failure, which can deter patients and healthcare providers from opting for this method. Additionally, the necessity for permanent catheter insertion outside the body raises concerns about long-term health risks and patient comfort. Furthermore, the complex and often lengthy approval processes for new dialysis devices can stifle innovation and limit the availability of improved treatment options. Together, these factors contribute to a cautious approach towards the adoption of peritoneal dialysis solutions in the healthcare sector.

Market Trends of the Global Peritoneal Dialysis Market

The global peritoneal dialysis market is witnessing significant growth, spurred by the rising prevalence of End Stage Renal Disease (ESRD) and associated conditions such as diabetes and hypertension. Increased public awareness and government initiatives aimed at expanding access to dialysis options are further enhancing market dynamics. The demand for advanced treatment technologies is also on the rise, reflecting a shift towards more efficient and patient-friendly solutions. Additionally, the growing adoption of peritoneal dialysis in developing regions like China and India presents new opportunities, positioning the market for sustained expansion in the coming years, driven by evolving healthcare needs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Trade Analysis
• Regulatory Analysis
• Patent Analysis
• Case Study Analysis

Global Peritoneal Dialysis Market Size by Offering & CAGR (2024-2031)

• Market Overview
• Peritoneal Dialysis Products
  • Peritoneal Dialysis Solution Bags
  • Peritoneal Dialysis Machines
  • Peritoneal Dialysis Catheters
  • Peritoneal Dialysis Transfer Sets
  • Other Peritoneal Dialysis Products
• Peritoneal Dialysis Services

Global Peritoneal Dialysis Market Size by Modality & CAGR (2024-2031)

• Market Overview
• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Global Peritoneal Dialysis Market Size by Disease Indication & CAGR (2024-2031)

• Market Overview
• End-Stage Renal Disease
• Acute Kidney Injury
• Other Diseases

Global Peritoneal Dialysis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Home Care Settings
• Hospitals & Independent Dialysis Centers
• Other End Users

Global Peritoneal Dialysis Market Size & CAGR (2024-2031)

• North America (Offering, Modality, Disease Indication, End User)
  • USA
  • Canada
• Europe (Offering, Modality, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Modality, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Modality, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Modality, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Fresenius Medical Care AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Utah Medical Products, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medionics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Newsol Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Dialysis Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• U.S. Renal Care, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Northwest Kidney Centers (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Relavo (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitra Industries Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huaren Pharmaceutical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Awak Technologies (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations